Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,069 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Radical prostatectomy for high-risk prostate cancer defined by preoperative criteria: oncologic follow-up in national multicenter study in 813 patients and assessment of easy-to-use prognostic substratification.
Ploussard G, Masson-Lecomte A, Beauval JB, Ouzzane A, Bonniol R, Buge F, Fadli S, Rouprêt M, Rebillard X, Gaschignard N, Pfister C, Villers A, Soulié M, Salomon L; Prostate Cancer Committee of the French Association of Urology. Ploussard G, et al. Among authors: roupret m. Urology. 2011 Sep;78(3):607-13. doi: 10.1016/j.urology.2011.05.021. Epub 2011 Jul 23. Urology. 2011. PMID: 21783233
Role of pelvic phased array magnetic resonance imaging in staging of prostate cancer specifically in patients diagnosed with clinically locally advanced tumours by digital rectal examination.
Xylinas E, Yates DR, Renard-Penna R, Seringe E, Bousquet JC, Comperat E, Bitker MO, Grenier P, Rouprêt M. Xylinas E, et al. Among authors: roupret m. World J Urol. 2013 Aug;31(4):881-6. doi: 10.1007/s00345-011-0811-z. Epub 2011 Dec 23. World J Urol. 2013. PMID: 22193518
Pathologic findings in radical prostatectomy specimens from patients eligible for active surveillance with highly selective criteria: a multicenter study.
Beauval JB, Ploussard G, Soulié M, Pfister C, Van Agt S, Vincendeau S, Larue S, Rigaud J, Gaschignard N, Rouprêt M, Drouin S, Peyromaure M, Long JA, Iborra F, Vallancien G, Rozet F, Salomon L; Members of Committee of Cancerology of the French Association of Urology (CCAFU). Beauval JB, et al. Among authors: roupret m. Urology. 2012 Sep;80(3):656-60. doi: 10.1016/j.urology.2012.04.051. Epub 2012 Jul 7. Urology. 2012. PMID: 22770616
Hepatitis C transmission after prostate biopsy.
Ferhi K, Rouprêt M, Mozer P, Ploussard G, Haertig A, de La Taille A. Ferhi K, et al. Among authors: roupret m. Case Rep Urol. 2013;2013:797248. doi: 10.1155/2013/797248. Epub 2013 Feb 21. Case Rep Urol. 2013. PMID: 23533934 Free PMC article.
European guidelines on upper tract urothelial carcinomas: 2013 update.
Rouprêt M, Babjuk M, Compérat E, Zigeuner R, Sylvester R, Burger M, Cowan N, Böhle A, Van Rhijn BW, Kaasinen E, Palou J, Shariat SF; European Association of Urology. Rouprêt M, et al. Eur Urol. 2013 Jun;63(6):1059-71. doi: 10.1016/j.eururo.2013.03.032. Epub 2013 Mar 19. Eur Urol. 2013. PMID: 23540953
Predictive factors of oncologic outcomes in patients who do not achieve undetectable prostate specific antigen after radical prostatectomy.
Ploussard G, Staerman F, Pierrevelcin J, Saad R, Beauval JB, Roupret M, Audenet F, Peyromaure M, Delongchamps NB, Vincendeau S, Fardoun T, Rigaud J, Villers A, Bastide C, Soulie M, Salomon L; Committee of Cancerology of the Association of French Urology. Ploussard G, et al. Among authors: roupret m. J Urol. 2013 Nov;190(5):1750-6. doi: 10.1016/j.juro.2013.04.073. Epub 2013 Apr 30. J Urol. 2013. PMID: 23643600
1,069 results